secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2021-12-23T23:59:59+00:00
Accession:  0001493152-21-032360
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics acquires Idaho Molecular and Advanced Conceptions for up to 4.72M shares and warrants
--------------------------------------------------------------------------------

- Total consideration: up to 4.72M shares of CODX common stock and 465,000 warrants at $9.125 exercise price.
- Acquisition provides all existing and future assets and IP for at-home/point-of-care PCR device (Eikon/YourTest).
- Closings expected by December 31, 2021; each target becomes wholly owned subsidiary of CODX.
- Dr. Kirk Ririe to become president of subsidiary; Dr. Carl Wittwer named Chairman of Scientific Advisory Board.
- CODX commits to fund development; deal streamlines commercialization and avoids future royalties.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315221032360/0001493152-21-032360-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315221032360/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-032360

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer